Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The GRASP trial has completed recruitment and will now begin its follow up phase.

GRASP logo

The GRASP trial is looking at the best ways to treat shoulder pain in people with a rotator cuff disorder. We are testing two different types of physiotherapy treatment pathways routinely used to treat people with rotator cuff problems. The study is also investigating whether a corticosteroid injection in the shoulder joint before starting physiotherapy helps relieve pain and improve patient function more quickly.

Since early 2017, 708 participants have been enrolled into the GRASP trial across 20 NHS Hospital Trusts in England. We have now finished the recruitment part of this study. Over the next 12 months we will be asking participants to complete questionnaires at 8 weeks, 6 and 12 months after they first entered into the study asking them about how their health, activity and shoulder pain. The trial results are anticipated in the summer/autumn of 2020.

We are very grateful to all of the patients who are taking part in the GRASP trial and to the clinical and research staff at our participating NHS Hospital Trust’s (

GRASP is funded by the National Institute for Health Research Health Technology Assessment Programme (ID: 15/26/06).

Similar stories

SCIENCE spreads across the world

Oxford Trauma are pleased to open their first overseas site for the SCIENCE study.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

PRoCuRe opens to recruitment

The Partial Rotator Cuff Tear Repair Trial (PRoCuRe) is open to recruitment at Oxford University Hospitals NHS Foundation Trust after achieving OCTRU Green Light approval!

IMP-MEL Trial given Green Light to open

OCTRU have now given Green Light approval for IMP MEL to open. This is a phase 1 first-in-human dose finding/randomised phase 2 study of IMM60 and pembrolizumab in advanced melanoma and NSCLC.

WISE opens to recruitment

The WISE Study - Wrist Injury Strengthening Exercise: a randomised multicentre feasibility study of resistance exercise versus usual care for optimising function after distal radius fracture in adults aged 50 years or over has now received OCTRU Green Light approval and has opened to recruitment.